ELAB
PMGC Holdings Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.21
−0.38%Margins
Gross margin
9.9%
EBITDA margin
-428.4%
EBIT margin
-451.4%
Net margin
-533.1%
FCF margin
-214.5%
-94.8%
Return on equity
-43.4%
Return on assets
-43.8%
Return on invested capital
0.10x
Asset turnover
-$5.9M
Cash from operations
$23
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026